LMH STRATEGIC SOLUTIONS

Lobbying for REGENXBIO INC. · Biotechnology company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Maryland · House · Senate · $60,000.00 income · posted Apr 17, 2026

Lobbying activity 2

Pharmacy

Healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry. General health care coverage and reimbursement for prescription drugs. Drug pricing reform. Food and Drug Administration legislative and regulatory issues.

Health Issues

Healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry. General health care coverage and reimbursement for prescription drugs.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.